NotesFAQContact Us
Collection
Advanced
Search Tips
Showing all 4 results Save | Export
Peer reviewed Peer reviewed
Direct linkDirect link
Prasher, V. P.; Airuehia, E.; Carey, M. – Journal of Applied Research in Intellectual Disabilities, 2010
Dementia with Lewy bodies (DLB) is the second commonest cause of dementia in the general population. Several researches have established an association between Down syndrome (DS) and Alzheimer's disease. Very few studies have however showed such an association between dementia with Lewy bodies and Down syndrome. The occurrence of DLB in persons…
Descriptors: Alzheimers Disease, Down Syndrome, Patients, Correlation
Peer reviewed Peer reviewed
Direct linkDirect link
Prandota, Joseph – Research in Autism Spectrum Disorders, 2011
"Toxoplasma gondii" is a protozoan parasite that infects about a third of human population. It is generally believed that in immunocompetent hosts, the parasite infection takes usually asymptomatic course and induces self-limiting disease, but in immunocompromised individuals may cause significant morbidity and mortality. "T. gondii" uses sulfated…
Descriptors: Metabolism, Autism, Alzheimers Disease, Diseases
Peer reviewed Peer reviewed
Direct linkDirect link
Margallo-Lana, M. L.; Moore, P. B.; Kay, D. W. K.; Perry, R. H.; Reid, B. E.; Berney, T. P.; Tyrer, S. P. – Journal of Intellectual Disability Research, 2007
Background: The clinical and neuropathological features associated with dementia in Down's syndrome (DS) are not well established. Aims: To examine clinico-pathological correlations and the incidence of cognitive decline in a cohort of adults with DS. Method: A total of 92 hospitalized persons with DS were followed up from 1985 to December 2000.…
Descriptors: Adjustment (to Environment), Adults, Patients, Incidence
Peer reviewed Peer reviewed
Direct linkDirect link
Pueschel, Siegfried M. – Research in Developmental Disabilities: A Multidisciplinary Journal, 2006
Since previous investigations reported improvements in cognition of patients with dementia after acetyl-L-carnitine therapy and since there is an increased risk for persons with Down syndrome to develop Alzheimer disease, this study was designed to investigate the effect of acetyl-L-carnitine administration on neurological, intellectual, and…
Descriptors: Down Syndrome, Alzheimers Disease, Adults, Psychological Testing